Director of Site Development
Vincent Napoli has been the Director of Site Development since 2017. He is responsible for the long-term pipeline needs of Insearch client sites as well as the quality requirements of participating Pharma and CROs. Vincent’s varied background has contributed to Insearch’s success. Prior to joining Insearch, Vincent was responsible for donor management with the University of Miami’s central Florida group. He previously held positions with RTI Surgical and the Lion’s Eye Institute.
Business Development Manager
Lara Wakeman joined Insearch in 2011. As a past employee of PPD, Inc., Lara has over 10 years of clinical trials experience in the CRO industry. While there, her responsibilities grew from Clinical Research Associate to Project Manager. Lara brings a strong understanding and appreciation for the dynamic interaction between Sponsor, CRO and research sites. She thoroughly enjoys developing relationships with colleagues to match sponsors/CROs with the best research centers across the country.
Stephanie L. Jones, MBA
Director of Marketing
Stephanie Jones joined Insearch in 2014. As the Director of Marketing, she is responsible for promoting Insearch to Sponsors, CROs and research sites. She has more than 20 years of marketing and advertising experience in healthcare, technology and financial services. Stephanie received her BA from the University of South Florida and MBA from Nova Southeastern University.
Kelly Toms joined Insearch in 2014 while finishing up her Bachelor of Arts degree from the University of South Florida. Kelly started as a data entry coordinator and quickly extended her knowledge into the sites’ regulatory affairs while also providing administrative assistance to the accounting department. Simultaneously, Kelly currently sits on the Healthcare Businesswomen’s Association Board of Directors in Florida, as the Director of Programming in the Tampa Bay region. Today, Kelly serves as the Business Development Research Analyst and works toward study acquisition on behalf of all Insearch’s Principal Investigators and their clinical sites.
CEO and President
Tony Busa has served in a management capacity in the clinical research provider industry for more than 25 years. He has worked for major central laboratories, late phase CROs, early phase CROs, bioanalytical laboratories and late phase site organizations throughout the United States including Scicor (Covance’s Central Laboratory Group), Covance Corporate, Esoterix, dgd Research (Diabetes Phase I, II and III) and WCT Early Phase and Bioanalytical Services Group.